Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1332 results

TAVI for aortic regurgitation

19 Nov 2023 – From PCR London Valves 2023

In the face of aortic regurgitation, learn about various TAVI rescue techniques in this session, including valve implantation in the descending aorta, TAVI treatment of aortic regurgitation with cardiogenic shock, and TAVI management of aortic regurgitation in a patient with a left ventricular assist device.

TAVI for aortic regurgitation

TAVI - Alternative access - Part 1

19 Nov 2023 – From PCR London Valves 2023

Learn more about the evolving landscape of TAVI techniques and access options with this session: experience the first-hand application of JenaValve Trilogy via transaxillary access in treating aortic regurgitation, delve into the challenges and solutions of transcaval TAVI in a patient with right iliac vein occlusion,...

TAVI - Alternative access - Part 1

TAVI: haemodynamic considerations

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain a comprehensive understanding of the hemodynamic considerations in TAVI: delve into the comparative analysis of invasive and echocardiographic assessments to discern transvalvular pressure gradients post-TAVI, witness the validation of non-invasive volume-pressure loop analysis as an effective tool for patients with aortic...

TAVI: haemodynamic considerations

The catheter-based treatment revolution is just getting started

19 Nov 2023 – From PCR London Valves 2023

Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.

The catheter-based treatment revolution is just getting started

TAVI and beyond: tackling coronary challenges

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain a comprehensive understanding of the crucial role of coronary access post-TAVI, and the impact of TAV design and implantation technique on coronary access. Gain some insights into the intricacies of coronary accessibility from extensive bench test work and the impact of TAV design in...

TAVI and beyond: tackling coronary challenges

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

19 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

TAVI in bicuspid anatomy - Part 1

19 Nov 2023 – From PCR London Valves 2023

Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: encounter a challenging scenario with a bicuspid aortic valve, where the ejection fraction is -14%, coupled with left ventricle thrombus and an aortic valve calcium score reaching 11,000, learn more about the...

TAVI in bicuspid anatomy - Part 1

TAVI in complex scenarios

19 Nov 2023 – From PCR London Valves 2023

What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!

TAVI in complex scenarios

New techniques for commissural alignment

19 Nov 2023 – From PCR London Valves 2023

Learn how to perfect your mastery of commissural alignment with the 3 cases presented in this session, which highlight new techniques: the use of coronary ostia overlap view, the octa align technique, and the RN cusp-overlap technique.

New techniques for commissural alignment

Cerebral protection devices

19 Nov 2023 – From PCR London Valves 2023

Consult the slides on this page to analyze the use of a latest-generation cerebral protection device, observe a transcatheter mitral valve-in-valve performed with cerebral protection in a TAVR case, or appreciate the value of cerebral protection in an anomalous aortic arch.

Cerebral protection devices

TAVI in cardiogenic shock

19 Nov 2023 – From PCR London Valves 2023

Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.

TAVI in cardiogenic shock

The mortality burden of untreated aortic stenosis

14 Nov 2023

This study, based on extensive real-world data, aimed to assess mortality rates across different untreated AS severities and AS treatment rates.

Alessandro Sticchi

Reviewer

Alessandro Sticchi

Reviewer

Giulia Costa
The mortality burden of untreated aortic stenosis

Cerebral embolic protection during TAVI: evidence meets practice

11 Nov 2023

Watch the replay of this webinar with D. Mylotte, C. Cook and R. Kharbanda to know more about the incidence and impact of TAVI associated stroke and much more!

Cerebral embolic protection during TAVI: evidence meets practice

Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis and small aortic annuli: A randomized clinical trial (the VIVA Trial)

27 Oct 2023

Luis Ortega-Paz interviews Josep Rodés-Cabau on the results of the VIVA trial which he presented at TCT Congress 2023 in San Francisco.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Josep Rodés-Cabau

Author

Josep Rodés-Cabau
Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Four-Year Outcomes from the EVOLUT Low Risk Trial

26 Oct 2023

Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)

Dejan Milasinovic

Author

Dejan Milasinovic
Four-Year Outcomes from the EVOLUT Low Risk Trial

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Nicola Ryan

Author

Nicola Ryan
Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)

Inner curvature technique for the implantation of a balloon-expandable valve

24 Oct 2023

Find out more about this technique that allows smooth and controlled navigation across the aortic arch along the inner curvature, facilitating the advancement and positioning of the delivery system, and avoiding unnecessary scraping of the aortic wall.

Won-Keun Kim

Author

Won-Keun Kim
Inner curvature technique for the implantation of a balloon-expandable valve

TAVI: from first valve to lifetime management

19 Oct 2023

Watch the replay of this webinar with T. Cuisset, O. De Backer and L. Rosseel to select the most appropriate TAV device for the index TAVI procedure and much more!

TAVI: from first valve to lifetime management